{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T14:03:59Z","timestamp":1765807439388},"reference-count":47,"publisher":"Royal College of General Practitioners","issue":"657","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Gen Pract"],"published-print":{"date-parts":[[2017,4]]},"abstract":"Background<\/jats:title>More than 200 opiate overdose deaths occur annually in Ireland. Overdose prevention and management, including naloxone prescription, should be a priority for healthcare services. Naloxone is an effective overdose treatment and is now being considered for wider lay use.<\/jats:p><\/jats:sec>Aim<\/jats:title> To establish GPs\u2019 views and experiences of opiate addiction, overdose care, and naloxone provision.<\/jats:p><\/jats:sec>Design and setting<\/jats:title> An anonymous postal survey to GPs affiliated with the Department of Academic General Practice, University College Dublin, Ireland.<\/jats:p><\/jats:sec>Method<\/jats:title>A total of 714 GPs were invited to complete an anonymous postal survey. Results were compared with a parallel GP trainee survey.<\/jats:p><\/jats:sec>Results<\/jats:title>A total of 448\/714 (62.7%) GPs responded. Approximately one-third of GPs were based in urban, rural, and mixed areas. Over 75% of GPs who responded had patients who used illicit opiates, and 25% prescribed methadone. Two-thirds of GPs were in favour of increased naloxone availability in the community; almost one-third would take part in such a scheme. A higher proportion of GP trainees had used naloxone to treat opiate overdose than qualified GPs. In addition, a higher proportion of GP trainees were willing to be involved in naloxone distribution than qualified GPs. Intranasal naloxone was much preferred to single (P<\/jats:italic><0.001) or multiple dose (P<\/jats:italic><0.001) intramuscular naloxone. Few GPs objected to wider naloxone availability, with 66.1% (n<\/jats:italic> = 292) being in favour.<\/jats:p><\/jats:sec>Conclusion<\/jats:title>GPs report extensive contact with people who have opiate use disorders but provide limited opiate agonist treatment. They support wider availability of naloxone and would participate in its expansion. Development and evaluation of an implementation strategy to support GP-based distribution is urgently needed.<\/jats:p><\/jats:sec>","DOI":"10.3399\/bjgp17x689857","type":"journal-article","created":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T01:10:36Z","timestamp":1488330636000},"page":"e267-e273","source":"Crossref","is-referenced-by-count":10,"title":["Opiate addiction and overdose: experiences, attitudes, and appetite for community naloxone provision"],"prefix":"10.3399","volume":"67","author":[{"given":"Tom\u00e1s","family":"Barry","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Klimas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helen","family":"Tobin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mairead","family":"Egan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerard","family":"Bury","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1987","published-online":{"date-parts":[[2017,2,28]]},"reference":[{"issue":"11","key":"2020081209301149000_67.657.e267.1","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.2105\/AJPH.2015.302843a","article-title":"Worldwide prevalence and trends in unintentional drug overdose: a systematic review of the literature","volume":"105","author":"Martins","year":"2015","journal-title":"Am J Public Health"},{"key":"2020081209301149000_67.657.e267.2","unstructured":"European Monitoring Centre for Drugs and Drug Addiction (2015) European drug report 2015: trends and developments (Publications Office of the European Union, Luxembourg) http:\/\/www.emcdda.europa.eu\/publications\/edr\/trends-developments\/2015 (accessed 18 Jan 2017)."},{"key":"2020081209301149000_67.657.e267.3","unstructured":"European Monitoring Centre for Drugs and Drug Addiction (2013) European drug report 2013: trends and developments (Publications Office of the European Union, Luxembourg) http:\/\/www.emcdda.europa.eu\/attachements.cfm\/att_213154_EN_TDAT13001ENN1.pdf (accesed 18 Jan 2017)."},{"key":"2020081209301149000_67.657.e267.4","unstructured":"Farrell M Barry J (2010) The introduction of the opioid treatment protocol (Health Service Executive, Dublin) http:\/\/www.drugsandalcohol.ie\/14458\/1\/Opioid_Treatment_Protocol%5B1%5D.pdf (accessed 18 Jan 2017)."},{"issue":"2","key":"2020081209301149000_67.657.e267.5","first-page":"10","article-title":"A chronic care service that actually works","volume":"32","author":"Hunter","year":"2015","journal-title":"Forum"},{"key":"2020081209301149000_67.657.e267.6","unstructured":"Health Research Board Drug-related deaths and deaths among drug users in Ireland 2013 figures from the National Drug-Related Deaths Index. 2015 (HRB, Dublin) 2015. http:\/\/www.hrb.ie\/uploads\/tx_hrbpublications\/NDRDI_web_update_2004-2013.pdf (accessed 19 Jan 2017)."},{"key":"2020081209301149000_67.657.e267.7","unstructured":"Road Safety Authority (2014) Road traffic deaths by road user and county 2007 to 2013. (Ballina, Co. Mayo), http:\/\/www.rsa.ie\/Documents\/Press%20Office\/County%20Report%202013%20Final%20(2).pdf (accessed 19 Jan 2017)."},{"issue":"456","key":"2020081209301149000_67.657.e267.8","first-page":"546","article-title":"Experience of heroin overdose among drug users attending general practice","volume":"50","author":"Cullen","year":"2000","journal-title":"Br J Gen Pract"},{"key":"2020081209301149000_67.657.e267.9","unstructured":"European Monitoring Centre for Drugs and Drug Addiction (2015) Preventing fatal overdoses: a systematic review of the effectiveness of take-home naloxone (Publications Office of the European Union, Luxembourg) http:\/\/www.emcdda.europa.eu\/attachements.cfm\/att_234376_EN_TDAU14009ENN.web_.pdf (accessed 18 Jan 2017)."},{"key":"2020081209301149000_67.657.e267.10","unstructured":"World Health Organization (2014) Community management of opiate overdose (WHO, Geneva) http:\/\/www.who.int\/substance_abuse\/publications\/management_opioid_overdose\/en\/ (accessed 18 Jan 2017)."},{"key":"2020081209301149000_67.657.e267.11","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.g6580"},{"key":"2020081209301149000_67.657.e267.12","doi-asserted-by":"publisher","DOI":"10.1111\/add.13265"},{"issue":"9912","key":"2020081209301149000_67.657.e267.13","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/S0140-6736(14)60022-2","article-title":"Does take-home naloxone reduce non-fatal overdose?","volume":"383","author":"Bennett","year":"2014","journal-title":"Lancet"},{"issue":"12","key":"2020081209301149000_67.657.e267.14","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/j.drugpo.2015.09.011","article-title":"Exploring the life-saving potential of naloxone: a systematic review and descriptive meta-analysis of take home naloxone (THN) programmes for opioid users","volume":"26","author":"McAuley","year":"2015","journal-title":"Int J Drug Policy"},{"issue":"3","key":"2020081209301149000_67.657.e267.15","first-page":"70","article-title":"Take home naloxone for Ireland","volume":"108","author":"Bury","year":"2015","journal-title":"Ir Med J"},{"key":"2020081209301149000_67.657.e267.16","unstructured":"Clarke A Eustace A (2016) Evaluation of the HSE Naloxone Demonstration Project (Health Service Executive, Dublin) http:\/\/www.hse.ie\/eng\/services\/publications\/SocialInclusion\/addiction\/Naloxonedemoproject.pdf (accessed 17 Jan 2017)."},{"key":"2020081209301149000_67.657.e267.17","first-page":"13","article-title":"Preventing opiate-related deaths in Ireland: the naloxone demonstration project","volume":"49","author":"Lyons","year":"2014","journal-title":"Drugnet Ireland"},{"issue":"4","key":"2020081209301149000_67.657.e267.18","doi-asserted-by":"crossref","first-page":"292","DOI":"10.7326\/M16-1348","article-title":"Mainstreaming naloxone through coprescription to patients receiving long-term opioid therapy for chronic pain","volume":"165","author":"Walley","year":"2016","journal-title":"Ann Intern Med"},{"key":"2020081209301149000_67.657.e267.19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drugpo.2016.09.008","article-title":"Primary care: a key route for distribution of naloxone in the community","volume":"38","author":"Klimas","year":"2016","journal-title":"Int J Drug Policy"},{"key":"2020081209301149000_67.657.e267.20","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2013-002563"},{"issue":"2","key":"2020081209301149000_67.657.e267.21","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s11845-013-0991-1","article-title":"Getting a handle on the general practice workforce in Ireland","volume":"183","author":"Teljeur","year":"2014","journal-title":"Ir J Med Sci"},{"issue":"10","key":"2020081209301149000_67.657.e267.22","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1016\/j.ajem.2014.07.017","article-title":"Urban overdose hotspots: a 12-month prospective study in Dublin ambulance services","volume":"32","author":"Klimas","year":"2014","journal-title":"Am J Emerg Med"},{"key":"2020081209301149000_67.657.e267.23","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1186\/s12909-015-0487-y","article-title":"Development and process evaluation of an educational intervention for overdose prevention and naloxone distribution by general practice trainees","volume":"15","author":"Klimas","year":"2015","journal-title":"BMC Med Educ"},{"key":"2020081209301149000_67.657.e267.24","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1186\/1472-6963-14-477","article-title":"The implications of regional and national demographic projections for future GMS costs in Ireland through to 2026","volume":"14","author":"Conway","year":"2014","journal-title":"BMC Health Serv Res"},{"key":"2020081209301149000_67.657.e267.25","unstructured":"Mattick RP Kimber J Breen C Davoli M (2014) Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database Syst Rev (2):CD002207."},{"key":"2020081209301149000_67.657.e267.26","unstructured":"Collins C O\u2019Riordan M (2015) The future of Irish general practice: ICGP member survey 2015 (Irish College of General Practitioners, Dublin)."},{"issue":"5","key":"2020081209301149000_67.657.e267.27","first-page":"19","article-title":"Overdose risk perceptions and experience of overdose among heroin users in Cork, Ireland. Preliminary results from a pilot overdose prevention study","volume":"17","author":"Horan","year":"2015","journal-title":"Heroin Addict Relat Clin Probl"},{"key":"2020081209301149000_67.657.e267.28","doi-asserted-by":"publisher","DOI":"10.1016\/S0955-3959(00)00070-0"},{"key":"2020081209301149000_67.657.e267.29","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2005.05.010"},{"key":"2020081209301149000_67.657.e267.30","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2011.03407.x"},{"issue":"7","key":"2020081209301149000_67.657.e267.31","doi-asserted-by":"crossref","first-page":"558","DOI":"10.3109\/10826084.2013.787099","article-title":"Barriers to medical provider support for prescription naloxone as overdose antidote for lay responders","volume":"48","author":"Green","year":"2013","journal-title":"Subst Use Misuse"},{"key":"2020081209301149000_67.657.e267.32","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1471-2296-15-12","article-title":"Reducing drug related deaths: a pre-implementation assessment of knowledge, barriers and enablers for naloxone distribution through general practice","volume":"15","author":"Matheson","year":"2014","journal-title":"BMC Fam Pract"},{"issue":"6","key":"2020081209301149000_67.657.e267.33","first-page":"538","article-title":"Can naloxone prescription and overdose training for opioid users work in family practice? Perspectives of family physicians","volume":"61","author":"Leece","year":"2015","journal-title":"Can Fam Physician"},{"key":"2020081209301149000_67.657.e267.34","doi-asserted-by":"crossref","unstructured":"Straus MM Ghitza UE Tai B (Sep 2, 2013) Preventing deaths from rising opioid overdose in the US \u2014 the promise of naloxone antidote in community-based naloxone take-home programs. Subst Abuse Rehabil 2013, (4).","DOI":"10.2147\/SAR.S47463"},{"key":"2020081209301149000_67.657.e267.35","unstructured":"Irish Focal Point (2014) 2014 National report (2013 data) to the EMCDDA by the Reitox National Focal Point. Ireland: new developments, trends (Health Research Board, Dublin) http:\/\/www.drugsandalcohol.ie\/23170\/1\/Irelandnationalreport2014.pdf (accessed 18 Jan 2017)."},{"key":"2020081209301149000_67.657.e267.36","doi-asserted-by":"crossref","unstructured":"Matheson C Porteous T van Teijlingen E Bond C (2010) Br J Gen Pract, Management of drug misuse: an 8-year follow-up survey of Scottish GPs. DOI: https:\/\/doi.org\/10.3399\/bjgp10X514783.","DOI":"10.3399\/bjgp10X514783"},{"issue":"5","key":"2020081209301149000_67.657.e267.37","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1080\/00952990701522740","article-title":"Methadone maintenance treatment (MMT) in general practice or in specialized centers: profile of patients in the Swiss Canton of Vaud","volume":"33","author":"Pelet","year":"2007","journal-title":"Am J Drug Alcohol Abuse"},{"issue":"515","key":"2020081209301149000_67.657.e267.38","first-page":"444","article-title":"The prescribing of methadone and other opioids to addicts: national survey of GPs in England and Wales","volume":"55","author":"Strang","year":"2005","journal-title":"Br J Gen Pract"},{"key":"2020081209301149000_67.657.e267.39","first-page":"22","article-title":"External review of methadone treatment protocol makes wide-ranging recommendations","volume":"37","author":"Lyons","year":"2011","journal-title":"Drugnet Ireland"},{"key":"2020081209301149000_67.657.e267.40","doi-asserted-by":"publisher","DOI":"10.2146\/ajhp130798"},{"key":"2020081209301149000_67.657.e267.41","doi-asserted-by":"publisher","DOI":"10.1080\/10903120290938797"},{"key":"2020081209301149000_67.657.e267.42","unstructured":"Pre-Hospital Emergency Care Council (2014) Clinical practice guidelines; advanced paramedic (PHECC, Naas, Co. Kildare), 5th edn."},{"issue":"1","key":"2020081209301149000_67.657.e267.43","doi-asserted-by":"crossref","first-page":"24","DOI":"10.5694\/j.1326-5377.2005.tb06550.x","article-title":"Randomised trial of intranasal versus intramuscular naloxone in prehospital treatment for suspected opioid overdose","volume":"182","author":"Kelly","year":"2005","journal-title":"Med J Aust"},{"key":"2020081209301149000_67.657.e267.44","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2009.02724.x"},{"issue":"4","key":"2020081209301149000_67.657.e267.45","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1111\/add.13209","article-title":"Clinical provision of improvised nasal naloxone without experimental testing and without regulatory approval: imaginative shortcut or dangerous bypass of essential safety procedures?","volume":"111","author":"Strang","year":"2016","journal-title":"Addiction"},{"issue":"12","key":"2020081209301149000_67.657.e267.46","first-page":"536","article-title":"FDA approves first naloxone nasal spray for opioid overdose","volume":"47","author":"Chitnis","year":"2015","journal-title":"Emerg Med"},{"key":"2020081209301149000_67.657.e267.47","unstructured":"Bellerose D Carew AM Lyons S (2011) HRB Trends Series 12: Trends in treated problem drug use in Ireland 2005 to 2010 (Health Research Board, Dublin) http:\/\/www.drugsandalcohol.ie\/16381\/1\/HRB_Trend_Series_12.pdf (accessed 18 Jan 2017)."}],"container-title":["British Journal of General Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.3399\/bjgp17X689857","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,25]],"date-time":"2022-02-25T19:45:35Z","timestamp":1645818335000},"score":1,"resource":{"primary":{"URL":"https:\/\/bjgp.org\/lookup\/doi\/10.3399\/bjgp17X689857"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,28]]},"references-count":47,"journal-issue":{"issue":"657","published-online":{"date-parts":[[2017,3,30]]},"published-print":{"date-parts":[[2017,4]]}},"alternative-id":["10.3399\/bjgp17X689857"],"URL":"https:\/\/doi.org\/10.3399\/bjgp17x689857","relation":{},"ISSN":["0960-1643","1478-5242"],"issn-type":[{"value":"0960-1643","type":"print"},{"value":"1478-5242","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,28]]}}}